NCT00928837View on ClinicalTrials.gov

Study of Flavocoxid (Limbrel) Versus Naproxen in Subjects With Moderate-Severe Osteoarthritis of the Knee

NACompletedINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

June 30, 2007

Study Completion Date

September 30, 2007

Conditions
Osteoarthritis
Interventions
DIETARY_SUPPLEMENT

Flavocoxid 500 mg

flavonoid mixture

DRUG

Naproxen

non-steroidal anti-inflammatory drug

OTHER

Placebo

Placebo

OTHER

flavocoxid 250 mg

Medical food product

Trial Locations (1)

16635

Alan Kivitz MD, Duncansville

Sponsors
All Listed Sponsors
lead

Primus Pharmaceuticals

INDUSTRY